Trials / Unknown
UnknownNCT03466749
Paclitaxel Eluting Balloon Catheter in Coronary De-novo Lesions Treatment in China
A Real-world Study in China: the Safety and Efficacy of Paclitaxel Eluting Balloon Catheter in Coronary De-novo Lesions Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this Real-world study in China is evaluating the Safety and Efficacy of Paclitaxel Eluting Balloon Catheter in Coronary de-novo lesions(target vessel diameter:2.5mm-4.0mm)Treatment. And the primary point of this study is the target lesion failure of 12 months after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Paclitaxel Eluting Balloon Catheter | Paclitaxel Eluting Balloon Catheter |
Timeline
- Start date
- 2018-02-22
- Primary completion
- 2020-02-22
- Completion
- 2020-12-31
- First posted
- 2018-03-15
- Last updated
- 2019-04-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03466749. Inclusion in this directory is not an endorsement.